Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:2.7.10.2 (focal adhesion kinase)
 44,029 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Recently a FES (functional electrical stimulation)-assisted rowing machine was developed to enhance cardiovascular training in people with spinal cord injuries. The machine was assessed in terms of its efficacy as a training tool. Six patients who were quadriplegic (C6-T1) and 2 who were paraplegic (T3-6) completed a series of three tests in succession: (1) leg stimulation only (quadriceps and hamstring groups)--'Stim', (2) arm row only--'Row' and (3) simultaneous row and stimulation--'R & S'. Measurements recorded included oxygen uptake (VO2), minute ventilation (Ve), respiratory exchange ratio (RER), heart rate (HR) and blood pressure (BP). In addition, 6 out of the 8 subjects took part in a qualitative assessment comprising a guided interview exploring the subject's perception of the machine and test. Significant increases in VO2 were demonstrated between the three tests with R & S producing mean steady-state values of 16.34 nm (+/- 0.74) ml/kg/min (83% of maximum). These values represented a 12% increase over Row alone. Of interest was the qualitative assessment which revealed that subjects perceived R & S to be easier than Row despite the higher levels of VO2 observed. The results suggest that the rowing machine represents a potentially valuable hybrid training device that may significantly reduce risk factors for cardiovascular disease and improve the quality of life of people with SCI.
 ...
PMID:Electrical stimulation-assisted rowing exercise in spinal cord injured people. A pilot study. 841 39

The FES oncogene was previously localized to human chromosome 15 by analysis of mouse x human somatic cell hybrids and to 15q26 by in situ hybridization of a radioactively labeled probe. In the present study, using fluorescence in situ hybridization, we have determined the precise map position of FES at 15q26.1.
 ...
PMID:Confirmation of 15q26.1 as the site of the FES protooncogene by fluorescence in situ hybridization. 844 35

The allele distribution of two STRs has been investigated in two populations, i.e. Turks (n = 203/200) and Germans (n = 414/402). The Turkish population showed 11 alleles in HumFES/FPS and 6 alleles in HumF13B while the German population had 9 (FES) and 8 (F13B) alleles respectively. Although the frequency profiles looked quite similar in both populations, there exist significant differences mainly due to alleles 8 and 10 (F13B) and allele 12 (FES). Four variant alleles have been sequenced and are described. Investigation of 368 (FES)/372 (F13B) meioses revealed no new mutations.
 ...
PMID:HumFES/FPS and HumF13B: Turkish and German population data. 854 66

The short tandem repeat system FES/FPS was amplified by the polymerase chain reaction (PCR) in 211 unrelated Austrians and analysed by horizontal, non-denaturing electrophoresis. The allele distribution was in Hardy-Weinberg equilibrium. No mutations were found in 25 families (50 meioses). The mean exclusion chance was 0.49, the discriminating power 0.86 and the heterozygosity rate 74.4%. Amplification could be achieved with as little as 100 pg of high molecular weight DNA, which could be reduced to 75 pg by using 32 instead of 30 cycles. By reamplifying 1 microliter for another 15 cycles, the threshold could be reduced to less than 20 pg. In a degradation experiment DNA extracted from bloodstains stored for up to 24 days in a moist chamber and DNA boiled for up to 18 min could be amplified.
 ...
PMID:Validation of the STR system FES/FPS for forensic purposes in an Austrian population sample. 866 55

Adolescent drug abuse clients (N = 176) and their mothers, in six different outpatient drug-free programs, were assessed at admission and at follow-up, 15 months after initiation of treatment. Family therapy sessions were offered in all six programs programs in addition to individual and group counseling. The pretreatment assessment procedures, and thus also the variables analyzed for prediction of treatment outcome, emphasized family measures (including the Family Environment Scale, the Family Adaptability and Cohesion Scale, the Parent-Adolescent Communication Inventory, and other information about the family and the parents). Multiple regression analysis determined which of three demographic variables and 39 other independent pretreatment predictor variables had a significant relationship with each of the six outcome criteria (dependent variables). Four of these outcome criteria were based on client information, and two were based on information provided by the mother. The more positively the family's functioning and relationships were described by the client at pretreatment, the more client improvement was reported by either client or mother at follow-up. Eleven of the 12 predictor variables that were found to be significantly related to any of the treatment outcome criteria were measures, at pretreatment, either of the client's perceptions of family functioning, or of his or her relationship with parents, particularly with the mother. These findings show the power of the family factors as indicators of prognosis. The predictor variable that was found to have the largest number of significant relationships, predicting three of the six outcome criteria, was the "family independence" dimension of the FES (i.e., "The extent to which family members are encouraged to be assertive, self-sufficient"). It appears that the FES instrument may be quite effective for predicting improvements in the behavior of adolescent drug-abusing clients.
 ...
PMID:Family and client characteristics as predictors of outpatient treatment outcome for adolescent drug abusers. 874 93

The short tandem repeat system FXIIIB was amplified by the polymerase chain reaction (PCR) on blood samples from 201 unrelated Austrians and analyzed by horizontal, non-denaturing polyacrylamide gel electrophoresis. The mean exclusion chance was 0.496, the discriminating power 0.883 and the heterozygosity rate 78.61%. In 50 families (100 meioses) no mutations were found. Sufficient amplification could be achieved with as little as 80 pg of high molecular weight cell line DNA, which could be reduced to 60 pg by using 32 instead of 30 cycles. By reamplifying 1 microliter for another 15 cycles, the threshold could be reduced to less than 20 pg. Nevertheless this sensitivity was only possible with cell line DNA, since reamplification of simulated stains proved to be problematical due to artifacts. In a degradation experiment. DNA extracted from bloodstains stored for up to 26 days in a moist chamber and DNA boiled for up to 18 min could be amplified. A quadruplex PCR with VWA, FES and amelogenin is proposed.
 ...
PMID:Validation of the STR system FXIIIB for forensic purposes in an Austrian population sample. 878 92

The authors aim to demonstrate the efficacy of FES (functional electro-stimulation) in the treatment of urinary incontinence. The study, which is still in progress, was started 5 years ago and includes 44 patients with urinary incontinence caused by stress, emergency, mixed incontinence and reflux. Three devices with different but equally effective characteristics were used and compared, even if the results obtained were more rapid using one particular method. The efficacy of FES was confirmed by the results obtained and by the regression of incontinence using electric stimulation alone. Less satisfactory results were obtained in those pathologies which could only be treated surgically. Perineal floor rehabilitation, both before and after surgery, and above all in cases in which there are no indications for surgery, must include the use of valid and efficient electrostimulation equipment in order to achieve urinary continence.
 ...
PMID:[Functional electric stimulation in urinary incontinence]. 881 57

To investigate whether exercise training can produce increases in bone mass in spinal cord-injured (SCI) individuals with established disuse osteopenia, nine subjects (age 28.2 years, time since injury 6.0 years, level of injury C5-T7) were recruited for a 9-month training program using functional electrical stimulation cycle ergometry (FES-CE), which produces active muscle contractions in the paralyzed limb. After training, bone mineral density (BMD, by X-ray absorptiometry) increased by 0.047 +/- 0.010 g/cm2 at the lumbar spine; changes in BMD at the femoral neck, distal femur, and proximal tibia were not significant for the group as a whole. In a subset of subjects training at > or = 18 W for at least 3 months (n = 4), BMD increased by 0.095 +/- 0.026 g/cm2 (+18%) at the distal femur. By 6 months of training, a 78% increase in serum osteocalcin was observed, indicating an increase in bone turnover. Urinary calcium and hydroxyproline, indicators of resorptive activity, did not change over the same period. Serum PTH increased 75% over baseline values (from 2.98 +/- 0.15 to 5.22 +/- 0.62 pmol/L) after 6 months' training, with several individual values in hyperparathyroid range; PTH declined toward baseline values by 9 months. These data establish the feasibility of stimulating site-specific increases in bone mass in severely osteopenic bone with muscle contractions independent of weight-bearing for those subjects able to achieve a threshold power output of 18 W with FES-CE. Calcium supplementation from the outset of training in osteopenic individuals may be advisable to prevent training-induced increases in PTH.
 ...
PMID:Bone mass and endocrine adaptations to training in spinal cord injured individuals. 883 Sep 90

Proto-oncogenes are genes coding for factors involved in cellular growth, reproduction, and differentiation. Cancer results through mutations of proto-oncogenes or through other mechanisms involving the products of proto-oncogenes. This study asks whether serum proteins immunologically related to the products of proto-oncogenes distinguish older men and women who manifest a new cancer during a 2-year follow-up. The authors conducted a nested case-control study that involved 248 men and women selected from a larger group of older (age > or = 65 years) healthy volunteers in a randomized clinical trial of preventive clinical services. Study subjects included 37 with a fatal cancer, 59 non-fatal breast, prostate, colon, or lung cancer, 58 hospitalized with at least one discharge diagnosis that coded to benign neoplasia (International Classification of Diseases, 9th Revision codes 210-239), and 94 randomly selected controls. Using seven monoclonal antibodies prepared against ras, erb-B, FES, myb, and SIS polypeptide sequences, immunoblots detected 17 proteins in serum collected from subjects before the clinical recognition of cancer. Five oncogene-related serum proteins appeared to distinguish older persons who manifested fatal (but not non-fatal) cancer over a brief (2-year) follow-up. Older persons hospitalized with benign neoplasia also had higher levels of these serum proteins. Relative to the 94 control subjects, a 52,000 dalton SIS-related protein (odd ratio (OR) = 5.9, 95% confidence interval (CI) 1.4-24.9) and a 35,000 dalton k-ras-related protein (OR = 11.3, 95% CI 1.2-104) were particularly common in serum from the 37 subjects who manifested a fatal cancer.
 ...
PMID:Oncogene-related serum proteins and cancer risk: a nested case-control study. 885 20

Mutation of the Bloom's syndrome (BS) gene, BLM, results in genomic instability. As the first step toward positional cloning of the gene, tight linkage of BLM and FES at 15q26.1 was detected by genotyping affected in families in which the parents are cousins, so-called homozygosity mapping. Linkage disequilibrium between BLM and FES was detected in Ashkenazi Jews with BS, confirming the linkage results and supporting the hypothesis that the increased frequency of the BS mutation in the Ashkenazim is due to founder effect. The mutated BLM gene is inherited identical by descent in BS persons whose parents are cousins or Ashkenazi Jewish; in persons whose parents do not share a common ancestor, BLM can be mutant at different positions within the gene. In such persons, crossing-over within BLM can occur to form a functionally wild-type gene capable of correcting the mutant phenotype of BS cells. In half the cases in which such somatic intragenic recombination had occurred, reduction to homozygosity was detectable distal to BLM but not proximal to it. We localized the cross-over points in corrected cells to a 250 kb genomic segment and isolated therefrom a 4437 bp cDNA that encodes a 1417 amino acid protein homologous to the RecQ subfamily of DExH box-containing DNA and RNA helicases. The identification of BLM as a putative DNA helicase provides a new and powerful tool to investigate the primary defect in BS and the function of the BLM gene product in maintaining the integrity of the genome.
 ...
PMID:Molecular genetics of Bloom's syndrome. 887 52


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>